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Transcriptional Mechanisms
Underlying Lymphocyte Tolerance
Activation of the cell-intrinsic mechanism of lympho-
cyte tolerance is closely linked to the cell-surface stimu-
lus received. In both T and B cells, combined activation
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of antigen and costimulatory receptors leads to full acti-1Center for Blood Research
vation of all TCR-coupled signaling pathways and culmi-Department of Pathology
nates in a productive immune response. In contrast,Harvard Medical School
tolerance is evoked, both ex vivo and in vivo, by unbal-200 Longwood Avenue
anced stimulation through antigen receptors without en-Boston, Massachusetts 02115
gagement of costimulatory receptors, or by stimulation2 Wyeth Research
with weak agonist antigens in the presence of full costi-200 CambridgePark Drive
mulation (Schwartz, 1996; Sloan-Lancaster and Allen,Cambridge, Massachusetts 02140
1996; Goodnow, 2001). In each system, the process of
tolerance induction may be conceptualized as occurring
in two stages. The tolerizing stimulus first elicits partialSummary
or suboptimal activation; next, the partially activated
lymphocytes enter a long-lasting unresponsive state, inIn lymphocytes, integration of Ca2 and other signaling
which they paradoxically become refractory to subse-pathways results in productive activation, while unop-
quent full stimulation with antigen and costimulatoryposed Ca2 signaling leads to tolerance or anergy. We
ligands (Schwartz, 1996; Sloan-Lancaster and Allen,show that the Ca2-regulated transcription factor
1996).NFAT has an integral role in both aspects of lympho-
The most consistent feature of tolerizing stimuli iscyte function. Ca2/calcineurin signaling induces a lim-
their ability to induce elevation of intracellular free Ca2.ited set of anergy-associated genes, distinct from
One of the simplest methods of inducing tolerance (an-genes induced in the productive immune response;
ergy) in T cells is treatment with the Ca2 ionophorethese genes are upregulated in vivo in tolerant T cells
ionomycin; conversely, anergy induction is blocked byand are largely NFAT dependent. T cells lacking NFAT1
the extracellular Ca2 chelator EGTA and by the cal-are resistant to anergy induction; conversely, NFAT1
cineurin inhibitor cyclosporin A (CsA) (Schwartz, 1996).induces T cell anergy if prevented from interacting
Ca2 has also been implicated in a well-establishedwith its transcriptional partner AP-1 (Fos/Jun). Thus,
model of B cell tolerance in vivo: B cells bearing an anti-in the absence of AP-1, NFAT imposes a genetic pro-
hen egg lysozyme (HEL) Ig transgene that have beengram of lymphocyte anergy that counters the program
tolerized to circulating antigen in vivo show a small butof productive activation mediated by the cooperative
significant elevation in their basal levels of intracellularNFAT:AP-1 complex.
free Ca2 and a concomitant increase in resting nuclear
levels of the Ca2-regulated transcription factor NFAT
Introduction (Healy et al., 1997). Ca2 is also implicated in anergy
imposed by altered peptide ligands, weakly agonistic
The antigen receptors of T and B cells recognize not peptide-MHC complexes that dissociate rapidly from
only antigens derived from pathogenic cells and organ- the T cell receptor. Measurements of Ca2 transients in
isms, but also self-antigens expressed on the body’s single cells show that these weak agonist peptides elicit
own tissues and nonpathogenic antigens responsible for much lower levels of Ca2 mobilization than strong ago-
allergic reactions. In healthy individuals, self-antigens do nist peptides, but increased Ca2 levels are maintained
not elicit a significant immune response. Self-reactive for much longer times (Rabinowitz et al., 1996; Sloan-
lymphocytes are clonally eliminated during develop- Lancaster et al., 1996).
ment; cells that survive this process are rendered toler- A major consequence of Ca2 mobilization is activa-
ant to self-antigens in the periphery (Kamradt and Mit- tion of the transcription factor NFAT (Rao et al., 1997;
chison, 2001). There are at least two mechanisms for Crabtree, 1999). NFAT is a family of highly phosphory-
inducing peripheral lymphocyte tolerance. The first is lated proteins residing in the cytoplasm of resting cells;
anergy induction, an intracellular process in which anti- when cells are activated, these proteins are dephos-
gen receptors become uncoupled from their down- phorylated by the Ca2/calmodulin-dependent phos-
stream signaling pathways (Fields et al., 1996; Li et al., phatase calcineurin, translocate to the nucleus, and be-
1996; Boussiotis et al., 1997). The second involves regu- come transcriptionally active (Kiani et al., 2000; Okamura
latory T cells, which limit the responses of other lympho- et al., 2000). In the nucleus, they cooperate with an
unrelated transcription factor, AP-1 (Fos/Jun), to inducecytes to self- and environmental antigens, in part by
a large number of cytokine genes and other genes thatproducing immunosuppressive cytokines such as TGF
are central to the productive immune response (Rao etand IL-10 (Maloy and Powrie, 2001).
al., 1997; Macian et al., 2001). Notably, NFAT activation
does not require strong stimulation of antigen receptors3 Correspondence: arao@cbr.med.harvard.edu
on B and T cells: substantial nuclear localization of NFAT4 These authors contributed equally to this work.
can be achieved with low, sustained levels of Ca2 mobi-5 Present address: Puerto Real University Hospital Research Unit/
School of Medicine, University of Ca´diz, Ca´diz, Spain. lization, such as those achieved by low concentrations
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of Ca2 ionophores, self-antigens, and low-affinity pep- by Th2 cells (lanes 6 and 8). Notably, Th1 and Th2 cells
differed significantly with respect to IL-10 gene expres-tide-MHC complexes (Dolmetsch et al., 1997). Costimu-
latory receptors are not coupled to Ca2 mobilization sion: Th1 cells showed a striking decrease in IL-10 tran-
script levels following ionomycin pretreatment (lanes 2and contribute only weakly to activation of NFAT (Lyakh
et al., 1997). Thus, NFAT activation occurs in response and 4), whereas Th2 cells were unaffected (lanes 6 and
8). Ionomycin pretreatment also did not affect IL-10to Ca2 signals or TCR stimulation alone, the precise
conditions needed to evoke anergy. In contrast, costi- mRNA induction by regulatory Tr1 cells, generated by
culturing stimulated CD4 T cells in media containing IL-mulation is critical for optimal activation of NFB and
AP-1: combined TCR/CD28 stimulation activates cJun 10 (Groux et al., 1997; S.-H.I., unpublished results). Thus,
the net effect of a tolerizing stimulus on T cells is tokinase (JNK), p38 MAP kinase, and IB kinase (IKK)
pathways and increases nuclear levels of NFB/Rel and skew the cytokine response toward production of the
immunosuppressive cytokine IL-10 while downregulat-AP-1 proteins more strongly than TCR stimulation alone
(Su et al., 1994; Harhaj and Sun, 1998). ing production of multiple effector cytokines associated
with a productive immune response.Here we demonstrate that NFAT plays a central role
in tolerance induction in T cells. Using a simple pharma- As previously noted (Schwartz, 1996), anergy induc-
tion required calcineurin activity (Figure 1F). DO11.10cological method of inducing T cell anergy, we show
that anergized T cells express a novel set of anergy- Th1 cells were stimulated overnight with immobilized
anti-CD3 in the presence or absence of the calcineurinassociated genes, distinct from those characteristic of
the productive immune response. These genes are also inhibitor CsA, then detached, washed thoroughly, cul-
tured for 2–3 days to remove both drug and stimulus,upregulated in vivo in T cells from orally tolerized mice.
T cells lacking a major NFAT protein, NFAT1 (NFATp, and restimulated with antigen/APC (Figure 1F). The CsA
washout was successful since it barely affected IL-2NFATc2), are resistant to anergy induction and show
significantly lower expression of many anergy-associ- production at later times (clusters 1 and 3); however,
CsA strongly impaired anergy induction by immobilizedated genes. Conversely, T cells harboring a constitu-
tively active NFAT1, under conditions where AP-1 is not anti-CD3 (clusters 2 and 4).
activated or NFAT: AP-1 cooperation does not occur,
show increased expression of anergy-associated genes A Gene Expression Program Activated
and display an anergic phenotype of lowered TCR re- by Ca2 and Calcineurin
sponsiveness. Thus, a single transcription factor, NFAT, Based on these data, we hypothesized that sustained
regulates two contrasting aspects of T cell function, Ca2/calcineurin signaling induced a distinct genetic
mediating nonoverlapping genetic programs of produc- program that correlated with the development of a long-
tive activation or anergy depending on the presence or lasting anergic state. To test the hypothesis, we evalu-
absence of its transcriptional partner AP-1. ated the gene expression profile of D5 T cells stimulated
for 2, 6, or 16 hr with ionomycin alone, which results in
anergy induction; with ionomycin plus CsA, whichResults
blocks anergy induction; and with ionomycin plus PMA,
which pharmacologically mimic complete stimulationSustained Ca2/Calcineurin Signaling Attenuates
Transcription of Effector Cytokine Genes through the TCR and CD28. Using Affymetrix oligonucle-
otide arrays, we identified 1358 genes and ESTs whoseWe used the murine antigen-specific Th1 clone D5 to
set up a model of clonal anergy ex vivo (Figure 1). As expression was altered at least 3-fold by any of the
treatments at one or more time points. Genes with simi-previously reported for other T cell clones (Schwartz,
1996), pretreatment of D5 T cells with ionomycin greatly lar expression patterns were clustered into 36 panels,
20 of which (736 genes and ESTs) are shown in Figurediminished their subsequent proliferative response to
antigen or anti-CD3 (Figures 1A and 1C and data not 2A. Known genes in the 20 panels are listed in Supple-
mentary Table S1 at http://www.cell.com/cgi/content/shown) without inducing detectable levels of apoptosis
(Figure 1B). As expected (Schwartz, 1996), anergy was full/109/6/719/DC1.
This analysis established that the effect of ionomycinovercome by exposure to IL-2 (Figure 1C). Anergy devel-
opment was slow: decreased antigen responses were stimulation on gene expression was distinct from that
of combined PMA/ionomycin stimulation, and moreoverapparent after 4–6 hr of ionomycin pretreatment, but
complete unresponsiveness was only achieved after 16 involved a much smaller number of genes (Figure 2A).
Only 205 genes/ESTs could be considered to be iono-hr (data not shown). Ionomycin-treated D5 cells showed
markedly decreased transcription of several inducible mycin induced: 165 were induced more strongly by
ionomycin than by PMA/ionomycin (panels 15–19), whilegenes, including IL-2, IFN-, TNF-, GM-CSF, and MIP-
1, in response to a second stimulation with anti-CD3/ 40 were equivalently induced by ionomycin and by
PMA/ionomycin (panels 13 and 14 plus a few in panelanti-CD28 or antigen/antigen presenting cells (APC)
(Figure 1D; the apparent lack of downregulation of IFN- 6; these are considered to be ionomycin-induced genes
on which PMA had no additional effect). In contrast, 585transcripts in lane 4 and of MIP-1 transcripts in lane
12 is due to probe saturation). genes/ESTs were upregulated (panels 1–12 and three
panels not shown) and 568 were downregulated (panelIonomycin pretreatment also reduced cytokine gene
transcription by primary T cells in response to TCR stim- 20 and 13 panels not shown) in response to PMA/iono-
mycin stimulation, with little or no change in responseulation (Figure 1E), essentially abrogating mRNA induc-
tion by Th1 cells (lanes 2, 4, 10, and 12) and decreasing to ionomycin alone. As expected (Teague et al., 1999;
Glynne et al., 2000; Feske et al., 2001), genes upregu-by 70% the induction of IL-4, IL-5, and IL-13 mRNAs
Transcriptional Regulation of T Cell Tolerance
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Figure 1. Ionomycin Pretreatment Attenuates T Cell Responses to Subsequent TCR/CD28 Stimulation
(A) 3 H-thymidine incorporation was measured in D5 T cells cultured with or without ionomycin for 16 hr, then washed and restimulated with
antigen/APC. Unless otherwise indicated, all subsequent experiments were performed using 16 hr pretreatment with 500 nM ionomycin.
(B) TUNEL assay showing that ionomycin treatment does not result in cell death.
(C) Ionomycin-pretreated T cells remain responsive to IL-2. D5 cells were incubated with or without ionomycin, then washed and stimulated
with antigen/APC with or without exogenous IL-2. 3 H-thymidine incorporation was measured. Results are mean and range of two experiments.
(D) Ionomycin pretreatment attenuates cytokine expression by D5 T cells. Cells were pretreated with ionomycin, then washed and stimulated
for 4 hr. Cytokine mRNA levels were determined by RNase protection assay.
(E) Ionomycin pretreatment attenuates most cytokine expression by primary Th1 and Th2 cells. Cells were pretreated with ionomycin, then
washed and stimulated with antigen/APC. Cytokine expression was determined by RNase protection assay.
(F) Anergy induction is inhibited by CsA. Th1 cells were incubated with or without 1 g/ml plate bound anti-CD3 in the presence or absence
of 1 M CsA for 16 hr. After washing and resting for 48–72 hr, cells were restimulated with antigen/APC for 24 hr. IL-2 levels were determined
by ELISA. Values are average  S.E.M. of three independent experiments.
lated by PMA/ionomycin included cytokine, chemokine, ations in expression were abolished by CsA, consistent
with our previous findings using human T cells (Feskeand other inducible genes characteristic of the produc-
tive immune response (IL-2, IFN-, GM-CSF, etc.; see et al., 2001). The results support the hypothesis that
Ca2/calcineurin signaling directs a genetic program as-Supplementary Table S1 at http://www.cell.com/cgi/
content/full/109/6/719/DC1). For almost all genes, alter- sociated with anergy development in T cells, distinct
Cell
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Figure 2. Stimulation with Ca2 Ionophore Activates a Calcineurin-Dependent Program of Gene Expression Distinct from that Induced by PMA
plus Ionomycin
(A) RNA was prepared from resting D5 T cells or cells stimulated for 2, 6, or 16 hr as indicated. Gene transcription profiles were evaluated
using Affymetrix oligonucleotide arrays. Genes whose expression levels were altered at least 3-fold in response to any of the treatments were
selected for clustering analysis using the self-organizing map (SOM) algorithm on the basis of kinetic expression pattern. The number of
clustered genes and ESTs is indicated inside each panel.
(B) Expression profiles of 18 specific genes chosen on the basis of their strong activation by ionomycin. The genes are grouped into six
categories based on function. Numbers within the panels indicate the fold induction of each transcript after stimulation with ionomycin for 2
hr, as confirmed by real time quantitative PCR. n.d. indicates not determined.
from that associated with the productive immune re- of70 of the205 anergy-associated genes/ESTs (e.g.,
see Figure 3C). Of the 37 known genes in this categorysponse (Glynne et al., 2000; Lechner et al., 2001). For
the remainder of this study, the ionomycin-induced (see Supplementary Table S2 at http://www.cell.com/
cgi/content/full/109/6/719/DC1), we selected 18 genes be-genes will be referred to interchangeably as “anergy-
associated” genes. cause of their robust and reproducible induction and
because their encoded gene products fell into poten-By repeating the DNA arrays with RNA prepared from
primary Th1 cells, we confirmed ionomycin inducibility tially interesting functional classes (Figure 2B). Like the
Transcriptional Regulation of T Cell Tolerance
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Figure 3. NFAT1/ Th1 Cells Show Reduced Expression of Anergy-Associated Genes
(A) NFAT1 is the predominant NFAT protein in resting T cells. Nuclear extracts from wild-type and NFAT1/ Th1 cells were tested in EMSAs
using an NFAT probe. Comparison of lanes 2 and 3 with lanes 4 and 5 shows that NFAT1 accounts for 90% of total NFAT DNA binding
activity in wild-type T cells. A control EMSA with an octamer probe showed equivalent binding activity in all lanes (not shown).
(B) NFAT1 regulates expression of many anergy-associated genes. Expression of 15 of the ionomycin-induced genes shown in Figure 2B was
examined by real-time quantitative PCR in ionomycin-stimulated wild-type and NFAT1/ Th1 cells. Results are represented as fold increase
over the levels of mRNA present in resting cells (set to 1). The average of two independent experiments is plotted.
(C) Gene transcription profiles of eight selected genes in wild-type and NFAT1/ Th1 cells obtained using Affymetrix oligonucleotide arrays.
All genes showed NFAT1-dependent induction in response to ionomycin. For jumonji, Rab10, and CD98, PMA/ionomycin-mediated induction
was not NFAT1 dependent and may be mediated by inducible isoforms of NFAT2 (Lyakh et al., 1997).
Ca2-dependent genes described in a separate study The Transcription Factor NFAT1 Participates
in Anergy Induction(Feske et al., 2001), the ionomycin-induced genes dis-
played diverse expression patterns consistent with dif- Since calcineurin activity is required for anergy induc-
tion, we tested the role of the calcineurin-regulated tran-ferential regulation by PMA- and ionomycin-induced sig-
naling pathways (Figure 2B). To validate the array data, scription factor NFAT. We first asked whether induction
of the anergy-associated genes was regulated, directlywe evaluated expression of 15 of the 18 genes in D5 T
cells by quantitative real-time PCR, and in every case or indirectly, by NFAT. To do this, we took advantage
of the fact that the NFAT family member NFAT1 is thewe were able to confirm ionomycin-mediated induction
(Figure 2B). predominant NFAT protein in resting T cells (Figure 3A).
Cell
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NFAT1/ T cells do not show compensatory increases
in other NFATs (F.M., unpublished); thus, these cells
not only lack all NFAT1, but also contain only about
10%–15% of the normal levels of total NFAT. About 35
of the 70 ionomycin-induced genes/ESTs, and 15 of
the 18 selected anergy-associated genes (Figures 3B
and 3C), showed significantly lower expression in
NFAT1/ relative to wild-type Th1 cells following iono-
mycin stimulation, consistent with participation in an
NFAT1-dependent anergy program. Twenty to twenty-
five genes were equivalently induced in wild-type and
NFAT1/ T cells, implying participation of transcription
factors other than NFAT1 (see Discussion). The re-
maining genes were upregulated in NFAT1/ relative
to wild-type T cells, suggesting loss of an inhibitory
signal mediated by NFAT1. The results implicate NFAT
proteins, directly or indirectly, in a substantial proportion
of ionomycin-induced gene transcription in T cells.
We asked whether NFAT1/ T cells were also defec-
tive for anergy induction ex vivo (Figure 4). As expected,
ionomycin pretreatment of DO11.10 TcR transgenic Th1
cells resulted in markedly decreased induction of IL-2
and IFN-mRNAs (Figure 4A, lanes 1 and 2). Because of
their lower levels of total NFAT, Th1 cells from NFAT1/
DO11.10 mice showed somewhat lower induction of cy-
tokine mRNAs compared to wild-type Th1 cells (1.5-fold
and 2-fold decrease for IL-2 and for IFN-, respectively,
lanes 1 and 3), but they were much less susceptible to
anergy induction, showing perceptible induction of IL-2
and IFN- mRNA even after ionomycin pretreatment
Figure 4. NFAT1/ T Cells Are More Resistant to Anergy Induction(Figure 4A, lane 4). Ionomycin-treated wild-type Th1
than Wild-Type T Cells
cells showed 18-fold and 12-fold decreases in IL-2 and
(A) Wild-type or NFAT1/ Th1 cells were incubated with or withoutIFN- transcripts following stimulation, but NFAT1/ T
ionomycin, then stimulated with antigen/APC or PMA/ionomycin for
cells showed only 2.5-fold decrease in either case (Fig- 4 hr. IL-2 and IFN- transcript levels were determined by RNase
ure 4A, right). The anergized cells were fully responsive protection assay (left). Unstimulated cells did not express detectable
cytokine transcripts. The graph on the right shows the anergy indexto PMA/ionomycin stimulation, which bypasses the
(fold reduction of cytokine transcript levels following ionomycin pre-membrane-proximal steps of TCR signal transduction
treatment) for IL-2 and IFN- in wild-type and NFAT1/ Th1 cells.(Figure 4A, lanes 5–8; note that the relative defect of
The results are representative of two independent experiments.the NFAT1/ T cells is overcome under these “strong”
(B) Th1 cells from wild-type or NFAT1/ DO11.10 transgenic mice
stimulation conditions). NFAT1/ Th1 cells did not be- were incubated with or without 1 g/ml plate bound anti-CD3 for
come anergic in response to anti-CD3 pretreatment, 16 hr. After resting for 48–72 hr, cells were restimulated with antigen/
APC, and IL-2 production was determined by ELISA. Values arecompared to wild-type T cells, which were effectively
average  S.E.M. of three independent experiments.anergized under these conditions (Figure 4B), again sup-
porting a role for NFAT1 and possibly other NFAT pro-
teins in anergy.
tolerized T cells showed upregulation of 13 of these 14
genes (Figures 5C and 5D). Thus, in vivo tolerized T cellsOrally-Tolerized T Cells Upregulate the Expression
exhibit a gene expression profile very similar to thatof Anergy-Associated Genes
observed in ex vivo anergized T cells, downregulatingTo ask whether anergy-associated genes were upregu-
production of IL-2 and other effector cytokines whilelated in tolerant T cells in vivo, we set up a model of
establishing a distinct Ca2/calcineurin-dependent pat-oral tolerance in which administration of high doses of
tern of gene expression. In vivo tolerized T cells alsoprotein antigens induces systemic, antigen-specific T
show basal elevation of intracellular Ca2 levels (V.cell tolerance in mice (Garside and Mowat, 2001). Oval-
Heissmeyer, S. Feske, S.-H.I., and A.R., unpublished),bumin (OVA) was administered to DO11.10 TCR trans-
suggesting strongly that T cell tolerance, like B cell toler-genic mice in their drinking water for 5 days, after which
ance (Healy et al., 1997; Goodnow, 2001), depends onCD4 T cells were isolated from spleen and lymph nodes
sustained low-level signaling through the Ca2/cal-and their response to OVA323–339 peptide was measured.
cineurin/NFAT pathway.As expected, T cells from OVA-fed mice showed pro-
foundly diminished proliferation and IL-2 production
compared to T cells from control transgenic mice that Anergy Is Induced by NFAT in the Absence
of AP-1 (Fos-Jun)had not been given OVA (Figures 5A and 5B). In parallel
we assessed expression of 14 selected ionomycin- NFAT:AP-1 cooperation is critical for transcription of
most genes induced during the productive immune re-induced genes by quantitative real-time PCR: the in vivo
Transcriptional Regulation of T Cell Tolerance
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Figure 5. Orally-Tolerized T Cells Upregulate Most Anergy-Associated Genes
(A and B) CD4 cells, isolated from spleen (spl) and lymph nodes (LN) of unfed or OVA-fed DO11.10 mice, were stimulated with different
concentrations of OVA323–339. Tolerized T cells show greatly diminished 3 H-thymidine incorporation (A) and IL-2 production (B) of antigen
responses compared to control (ctrl) T cells. One of four representative experiments is shown.
(C) Relative expression of 14 anergy-associated genes in tolerized versus non-tolerized T cells. Transcript levels were analyzed by real-time
quantitative PCR in control and OVA-tolerized CD4 T cells. Bars are grouped according to the functional categories of Figure 2B. Results are
average  S.D. of four independent experiments.
(D) PCR analysis using [32P]dCTP and 2-fold serial dilutions of cDNA. For the four genes displayed at top, the signal from tolerized T cells is
higher than the signal from control T cells. There was no change in levels of FasL mRNA. L32 levels serve as an internal control.
sponse (Rao et al., 1997; Kiani et al., 2000; Macian et pression in response to PMA stimulation, as expected
from the lack of activation of endogenous NFAT (lanesal., 2001). We asked whether NFAT:AP-1 cooperation
was required for anergy induction as well. Electropho- 1 and 2). Cells transfected with the CA-NFAT1 plasmid
showed perceptible basal induction of the TNF generetic mobility shift assays showed that ionomycin-
induced anergy correlated with NFAT but not AP-1 or (lane 3), an NFAT-dependent gene that can be tran-
scribed in the absence of NFAT-AP-1 cooperation (Gold-NFB activation (Figure 6A, lanes 2, 5, and 8), while
combined stimulation with PMA and ionomycin induced feld et al., 1993; Macian et al., 2000), as well as strong
PMA-stimulated induction of the IL-3, GM-CSF, andthe cooperative NFAT:AP-1 complex, the AP-1 complex,
and the p50/p65 NFB complex as expected (closed MIP-1 genes, which require the cooperative interaction
of NFAT and AP-1 (lane 4; Macian et al., 2000). PMAsymbols, lanes 3, 6, and 9).
To explore the role of NFAT:AP-1 cooperation in an- stimulation also further upregulated TNF, a gene that
normally is maximally activated under conditions ofergy induction, we utilized a constitutively active (CA)
version of NFAT1 (Okamura et al., 2000). This protein combined PMA/ionomycin stimulation (Macian et al.,
2000).bears alanine substitutions in 12 phosphorylated serines
whose dephosphorylation is required for nuclear local- Despite the ability of CA-NFAT1 to activate gene tran-
scription, both CA-NFAT1 and CA-RIT-NFAT1 paradoxi-ization and is constitutively nuclear under conditions
where endogenous NFAT proteins are fully localized to cally reduced TCR responsiveness when retrovirally ex-
pressed in unstimulated NFAT1/ Th1 cells (Figures 6Cthe cytoplasm (Okamura et al., 2000). We also generated
CA-RIT-NFAT1, a CA-NFAT1 derivative engineered to and 6D). Five to seven days after infection with IRES-
GFP retroviruses, the ability of GFP (infected) and GFPbe incapable of cooperation with AP-1. In addition to
the 12 Ser to Ala substitutions present in CA-NFAT1, (uninfected) cells to produce IL-2 in response to anti-
CD3/anti-CD28 stimulation was assessed by intracellu-CA-RIT-NFAT1 contains three point mutations in its DNA
binding domain that abrogate Fos-Jun interaction lar cytokine staining. T cells expressing CA-NFAT1 or
CA-RIT-NFAT1 showed markedly decreased IL-2 pro-(R468A/I469A/T535G; Macian et al., 2000).
We first showed that CA-NFAT1 could activate the duction, compared to control T cells expressing GFP
alone (Figure 6C, compare top and bottom; the resultstranscription of endogenous inducible genes (Figure
6B). Untransfected Jurkat cells showed no cytokine ex- of four independent experiments are presented in Figure
Cell
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Figure 6. NFAT Induces T Cell Anergy in the Absence of AP-1 (Fos-Jun)
(A) Ionomycin treatment activates NFAT but not AP-1 or NFB. EMSAs were performed with nuclear extracts of unstimulated or stimulated
Th1 cells and labeled NFAT, AP-1, or NFB probes. DNA-protein complexes are indicated as follows. Left: open circle, NFAT; closed circle,
cooperative NFAT:AP-1 complex. Middle: closed circle, AP-1 complex. Right: open triangle, NFB1(p50) homodimer; closed circle, NFB1(p50)/
RelA(p65) heterodimer.
(B) Constitutively active (CA) NFAT1 induces expression of endogenous cytokine genes. Jurkat T cells were cotransfected with expression
plasmids encoding mouse CD4 and either GFP or CA-NFAT1. Productively transfected cells expressing mouse CD4 were isolated and
stimulated with PMA as indicated, and cytokine transcript levels were analyzed by RNase protection assay. Endogenous (Endog) NFAT is
unable to induce cytokine expression under these conditions (lanes 1 and 2).
(C) Constitutive expression of CA-RIT-NFAT1 renders T cells unresponsive to TCR/CD28 stimulation. NFAT1/ Th1 cells were infected with
GFP or CA-RIT-NFAT1/GFP retroviruses (RV), then cultured for 3 days with and 24 hr without IL-2. The cells were then stimulated for 4 hr
with anti-CD3/anti-CD28, and the percentage of IL-2-producing cells in GFP (infected) and GFP (uninfected) cells was determined by
intracellular cytokine staining. Left: dot plot showing GFP and IL-2 expression by individual T cells. Two different gates were used: total GFP
cells (continuous vertical line) and cells expressing high levels of GFP (dotted vertical line). Middle and right: open and closed histograms
show IL-2 staining in unstimulated and stimulated cells gated for total or high GFP expression.
(D) Average  S.D. of four independent experiments similar to that shown in part (C). Cells were infected with GFP, CA-NFAT1, or CA-RIT-
NFAT1 retroviruses. Inset, CA-NFAT1 and CA-RIT-NFAT1 expression in infected populations of NFAT1/ cells was estimated by immunoblotting
with an anti-NFAT1 antibody. Expression levels are lower than those of endogenous NFAT1 in wild-type T cells.
(E) Constitutive expression of CA-RIT-NFAT1 induces expression of some but not all anergy-associated genes. NFAT1/ Th1 cells were
infected with GFP and CA-RIT-NFAT1 retroviruses and sorted for GFP expression. RNA was isolated from sorted cells, and levels of anergy-
associated genes were determined by quantitative real-time PCR. mRNA expression in CA-RIT-NFAT1-expressing cells is plotted relative to
that in control GFP-expressing cells. Results are average  S.D. of three independent experiments except for GRG-4, Ikaros, and LDHA, for
which the mean and range of two independent experiments is shown.
6D). When total and bright GFP cells were compared, 20-fold lower than its affinity when it forms a cooperative
NFAT:AP-1 complexes on the same site (G. Powers andthere was a clear correlation between the levels of GFP/
CA-RIT-NFAT1 expression and the extent to which IL-2 P.G. Hogan, personal communication; Jain et al., 1993).
Together, these results establish that continuous, low-production was reduced (Figure 6C). Note that the con-
stitutively active proteins are not overexpressed (see level activation of NFAT1 induces a state similar to clas-
sical anergy, in which T cells are significantly less capa-inset in Figure 6D), ruling out a dominant-negative mech-
anism in which CA-RIT-NFAT1 competes with endoge- ble of producing IL-2 in response to TCR stimulation.
Notably, NFAT:AP-1 cooperation is not required for thisnous NFAT for binding to the IL-2 promoter. This mecha-
nism is unlikely in any case, since without AP-1, the process of anergy induction. Stimulation of CA-RIT-
NFAT1-expressing T cells with PMA and ionomycin re-affinity of NFAT for composite NFAT:AP-1 sites is at least
Transcriptional Regulation of T Cell Tolerance
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Figure 7. A Model of Anergy Induction
For details, see text.
stored IL-2 expression substantially (data not shown), unbalanced activation of NFAT relative to its cooperat-
ing transcription factor AP-1 (Fos/Jun), thus divertingindicating that the anergy involved a TCR-proximal
block in signaling which could be overcome with phar- NFAT toward transcription of an alternate set of anergy-
associated genes whose products together impose themacological agents that bypassed the TCR.
Constitutive expression of CA-RIT-NFAT1 induced the tolerant state (Figure 7B). This model does not exclude
the participation of nontranscriptional mechanisms de-transcription of specific anergy-associated genes (Fig-
ure 6E). CA-RIT-NFAT1 was retrovirally expressed in pendent on Ca2 signaling, or participation of Ca2-regu-
lated transcriptional modulators other than NFAT.NFAT1/ Th1 cells, GFP cells were isolated by cell
sorting, RNA was prepared from the unstimulated cells, The model is consistent with essentially all previous
data on tolerance induction, both in vivo and ex vivoand expression of 13 anergy-associated genes was as-
sessed by real-time PCR. At least 4 of the 13 genes (see Introduction). Our supporting experimental data are
as follows. First, T cells lacking NFAT1, the major NFATshowed increased expression in CA-RIT-NFAT1-
expressing cells relative to cells expressing GFP alone protein expressed in resting cells, are more resistant
than wild-type T cells to anergy induction ex vivo, con-(Figure 6E), indicating that NFAT1 is sufficient as well
as necessary (Figure 3B) to induce expression of these sistent with previous findings of T and B cell hyperproli-
feration in mice lacking NFAT1 (Hodge et al., 1996; Xan-genes. In contrast, NFAT1 did not induce (or only moder-
ately induced) expression of 8 of the 13 genes (Figure thoudakis et al., 1996) or both NFAT1 and NFAT2 (Peng
et al., 2001). Second, T cells anergized with ionomycin6E), although it clearly participated in their induction
(Figures 3B and 3C). Thus, the transcriptional arm of show selective NFAT activation as well as induction of
a novel set of anergy-associated genes; these genesthe anergy program requires not only NFAT1, but also
additional signaling pathways and transcription factors are distinct from those activated during the productive
immune response and encode diverse categories of pro-induced by Ca2 or Ca2/calcineurin signaling.
teins that could plausibly impose an anergic state (dis-
cussed below). Third, the anergy-associated genes areDiscussion
also upregulated in T cells rendered tolerant to high
dose oral antigen in vivo. Fourth, a substantial numberA Model of Anergy Induction
of anergy-associated genes are direct or indirect targetsBased on our data, we propose that NFAT plays a central
of NFAT, since they are expressed at significantly lowerrole, not only in productive activation of lymphocytes
levels in NFAT1/ T cells following ionomycin stimula-but also in lymphocyte tolerance. Our model of tolerance
tion. Fifth, constitutively active versions of NFAT1, whichinduction is depicted in Figure 7. Combined stimulation
cannot cooperate productively with AP-1, are capableof TCR and costimulatory receptors results in balanced
of downregulating IL-2 production when retrovirally in-activation of NFAT, AP-1, and NFB; the cooperative
troduced into NFAT1-deficient Th1 cells.NFAT:AP-1 complexes formed under these conditions
Anergy induction is likely to require not only NFAT1,are necessary for transcription of cytokine genes and
but also other NFAT proteins and other nuclear factorsother genes critical for the productive immune response
induced by Ca2/calcineurin signaling. Although NFAT1/(Figure 7A). In contrast, TCR stimulation without costi-
T cells are resistant to anergy induction (Figure 4), theymulation results in higher activation of the Ca2 arm of
can be rendered anergic by high concentrations of iono-the TCR signal transduction pathway relative to the
PKC/IKK/Ras/MAP kinase arm; these conditions lead to mycin or immobilized anti-CD3 (F.G.-C., F.M., unpub-
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lished). These data suggest that NFAT2 and NFAT4 also 2000); diacylglycerol kinase-, which metabolizes the
participate in anergy induction, making increasing con- diacylglycerol required to activate protein kinases C
tributions as stronger anergizing stimuli are used. More- (Sanjuan et al., 2001); and the cell-surface receptor
over, half of the anergy-associated genes are not af- CD98, which is coupled to increased GTP loading of the
fected by NFAT1 deficiency, suggesting redundant small G protein Rap1 (Suga et al., 2001). Rap1 activation
effects of NFAT2 and NFAT4. It is likely that other Ca2/ has been linked to impaired activation of the ERK MAP
calcineurin-regulated nuclear factors also have a role: kinase pathway in anergic T cells (Boussiotis et al., 1997;
ionomycin pretreatment induces T cell anergy more ef- Bos, 1998).
fectively than CA-NFAT1 (Figures 1, 6C, and 6D), and Our data also suggest that proteolytic mechanisms
CA-NFAT1 does not upregulate the entire panel of iono- contribute to anergy induction. The procaspase 3 gene
mycin-inducible genes (Figures 2 and 6E). Plausible can- is robustly induced under conditions of anergy induction
didates include Elk-1 and MEF2 family members, which (Figures 2 and 3), and caspase 3 has been implicated
are known to be regulated by calcineurin; NFAT-MEF2 in modulating lymphocyte responses under conditions
cooperation has already been documented for other where its activation does not appear to be associated
cell types and genes (Aramburu et al., 2000; Olson and with cell death (Alam et al., 1999). Thus, caspase 3 might
Williams, 2000). implement T cell anergy in a manner unrelated to apo-
ptosis by cleaving specific signaling proteins down-
Relation between Anergy Induction and Cell Death stream of the TCR; its reported targets in the T cell
Our model also explains the fact that anergy is frequently activation pathway include Vav1, PKC-theta, the adap-
associated with activation-induced cell death (AICD) (Li tor protein Gads, and the zeta chain of the TCR/CD3
et al., 2000; Kamradt and Mitchison, 2001). Mice injected complex (Datta et al., 1997; Gastman et al., 1999; Hof-
with high doses of soluble antigen or with superantigens mann et al., 2000; Yankee et al., 2001). SOCS-2 and
(proteins that interact simultaneously with MHC Class Traf5 are also products of anergy-associated genes; like
II and the V region of the TCR) delete large numbers the related proteins SOCS-1 and Traf6 (Kamizono et al.,
of reactive cells, but the surviving cells are tolerant to 2001; Wang et al., 2001), these proteins may be E3 li-
subsequent stimulation (Garside and Mowat, 2001). gases involved in ubiquitin transfer. Indeed, mice lacking
Since all the signaling pathways shown in Figure 7A can the E3 ligases Itch and Cbl-b show a striking autoim-
be activated by TCR stimulation alone, we postulate mune phenotype (Perry et al., 1998; Bachmaier et al.,
that both NFAT and AP-1 are induced early in response 2000; Chiang et al., 2000), suggesting that protein degra-
to high circulating concentrations of antigen or superan- dation has a role in lymphocyte tolerance. Directed pro-
tigen, but while NFAT activation is relatively uniform, the
teolysis of specific signaling components in anergic T
extent of AP-1 activation depends on the strength of the
cells could explain the long-lasting nature of anergy in
stimulus encountered by the individual T cell, yielding a
vivo and ex vivo (Schwartz, 1996; Lanoue et al., 1997),
population of reactive cells that express a wide range
as well as the finding that anergy is dominant in somaticof relative NFAT:AP-1 ratios. NFAT:AP-1 cooperation is
cell fusion experiments (Telander et al., 1999).required for AICD (Macian et al., 2000), and thus cells
Ex vivo, activation of NFAT without AP-1 blocks allwith the highest AP-1 levels would succumb to AICD
Th1 cytokine production and skews the cytokine profilewhile those with the lowest levels of AP-1 would become
of Th2 cells toward IL-10 production (Figure 1E). A simi-anergic. Costimulation would affect both aspects of this
lar skewing toward IL-10 expression has been reportedprocess: it provides a strong survival stimulus by activat-
in tolerant T cells in vivo (Buer et al., 1998). Preferentialing PI-3 kinase and Akt and Bcl family members (Boise et
IL-10 production by anergic T cells provides a link be-al., 1995; Kane et al., 2001), thus promoting proliferation
tween the two current models of how peripheral tolerancerather than cell death, and at the same time it potentiates
is maintained: the cell-intrinsic mechanism of anergy in-MAP kinase/AP-1 and IKK/NFB pathways (Su et al.,
duction would attenuate the antigen responsiveness of1994; Harhaj and Sun, 1998), thus diminishing the proba-
differentiated effector T cells, while the bias toward IL-bility that a cell will become anergic. However, we em-
10 production by Th2 and Tr1 cells would lead to somephasize that T cells anergized with ionomycin ex vivo
immunosuppression by itself but would also result, overshowed no evidence of cell death in our experiments
the longer term, in generation of IL-10-producing regula-(Figure 1B), despite increased expression of FasL mRNA
tory T cells capable of suppressing any remaining pro-(Figures 2 and 3) and active caspase 3 protein (F.M.,
ductive response (Buer et al., 1998; Maloy and Powrie,unpublished). This is likely to reflect their lack of AP-1
2001). The cell type- and gene-specific inhibition of cyto-activation (Figure 6A) as well as the ability of Ca2 signal-
kine gene transcription observed in anergic T cells ising to downregulate Fas mRNA (Feske et al., 2001).
likely to be imposed in the nucleus by transcriptional
modulators that act on specific genes, rather than in theMechanisms of Anergy Induction
cytoplasm by global interference with the TCR signalingOur data support the existence of distinct mechanisms
complex. Candidate transcriptional modulators emerg-of tolerance induction in lymphocytes. The first is simple
ing from our screens include Ikaros, a family of proteinsinterference with signaling pathways coupled to antigen
implicated in gene silencing (Brown et al., 1997; Sabbat-receptors (Fields et al., 1996; Li et al., 1996; Boussiotis
tini et al., 2001); the Groucho-related protein Grg4 (Eber-et al., 1997; Healy et al., 1997). This process could be
hard et al., 2000); and the DNA binding protein jumonjimediated by the protein products of several of the an-
that negatively regulates cell proliferation (Toyoda et al.,ergy-associated genes we have identified, including sol-
uble and receptor tyrosine phosphatases (Li and Dixon, 2000).
Transcriptional Regulation of T Cell Tolerance
729
NFAT1/ Th1 cells 24 and 48 hr after stimulation with 1 g/ml plateTherapeutic Implications
bound anti-CD3	 and 5 g/ml anti-CD28 (Pharmingen) in mediaIn transplant patients, interference with costimulatory
supplemented with 20 U/ml of IL-2. Cells were analyzed 72 hr postin-pathways leads to tolerance induction; paradoxically,
fection and if necessary sorted for GFP expression. Infection effi-
this process is blocked by CsA (Li et al., 1998). Our ciencies were similar for all three retroviruses, ranging between 10%
model explains both findings and offers an alternate and 40% in different experiments. Protein expression was confirmed
by Western analysis.strategy that might synergistically induce tolerance in
combination with costimulatory blockade. The predic-
ELISAtion is that even in the presence of ongoing immune
Supernatants were collected 24 hr after T cell activation, and IL-2stimulation, disrupting the interaction of NFAT with Fos
levels were measured in a sandwich ELISA (Pharmingen).
and Jun would induce a long-lasting tolerant state: it
would eliminate or severely disrupt transcription of Immunoblotting
genes involved in the productive immune response for Whole cell extracts were prepared by boiling cell pellets directly in
SDS to prevent proteolysis during cell lysis. Anti-NFAT1 antibodieswhich NFAT-AP-1 cooperation is essential, while at the
have been described (Okamura et al., 2000).same time switching the cell’s genetic program toward
transcription of the distinct set of anergy-inducing genes
Proliferation Assaythat are activated by NFAT in the absence of AP-1. A
D5 or primary T cells were stimulated with APC and antigen, 3 H-
detailed molecular structure of the NFAT-Fos-Jun-DNA thymidine (10 Ci/ml) was added, and incorporation was measured
complex is available (Chen et al., 1998) and should facili- during a 16 hr pulse beginning at 24 hr following stimulation. DNA
tate identification of peptide and small molecule inhibi- was collected using a cell harvester, and the amount of radioactivity
incorporated was measured in a  counter.tors that selectively disrupt cooperative NFAT:Fos:Jun
complexes on composite NFAT-AP-1 sites, without af-
Tunel Assayfecting independent binding of NFAT or Fos:Jun to non-
Apoptosis was detected by the Tunel method using the In situ Cell
composite sites. Death Detection kit (Boehringer). Stained cells were analyzed on a
FACSCAN (Beckton-Dickinson).
Experimental Procedures
RNA Samples and DNA Array Procedures
Mice See Supplementary Methods at http://www.cell.com/cgi/content/
Mice were maintained in pathogen-free conditions in a barrier facil- full/109/6/719/DC1.
ity. BALB/cJ DO11.10 TCR transgenic mice were bred with NFAT1/
mice (Xanthoudakis et al., 1996) or their isogenic wild-type controls Intracellular Cytokine Staining
to obtain NFAT1/ or wild-type DO11.10 TCR transgenic mice. T cells were stimulated for 4 hr with 1 g/ml plate bound anti-CD3	
and 5 g/ml anti-CD28. For the last 2 hours, Brefeldin A was added
Cell Culture at 10 g/ml to promote intracellular accumulation of IL-2. After
The murine Th1 cell clone D5 (Ar-5) was cultured as previously stimulation, cells were fixed in 4% paraformaldehyde and perme-
described (Agarwal and Rao, 1998). Primary CD4 T cells were abilized in PBS/1% BSA/0.5% saponin. Cells were then washed and
isolated from lymph nodes and spleen of NFAT1/ or wild-type incubated for 10 min with Fc-block (Pharmingen) and then for 30
DO11.10 transgenic mice using magnetic beads (Dynal) and differ- more minutes with 10 g/ml phycoerythrin (PE)-conjugated anti-
entiated in vitro by stimulating for 1 week with irradiated APC and mouse IL-2 antibody (Pharmingen) to detect intracellular IL-2.
1 g/ml OVA323–339 as previously described (Agarwal and Rao, 1998). Stained cells were analyzed on a FACSCAN (Beckton-Dickinson).
Jurkat and Phoenix Ecotropic cells were cultured in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal calf serum, Quantitative RT-PCR
10 mM HEPES, and 2 mM glutamine. Total RNA was prepared from resting or stimulated T cells using
Ultraspec reagent (Biotecx). cDNA was synthesized using oligo-
RNase Protection Assay dT primers and Superscript polymerase (Invitrogen) following the
Total cellular RNA was analyzed using the RiboQuant multiprobe manufacturer’s recommendations. Quantitative real-time PCR was
RNase protection kit and specific multiset probes (Pharmingen). performed in an I-Cycler (BioRad) using a SYBR Green PCR kit from
Jurkat cells were selected after transfection with 10 g/106 cells of Applied Biosystems and specific primers to amplify 100–200 bp
a murine CD4 plasmid and pEGFPN1 (Clontech) or pNFAT1-NLS- fragments from the different genes analyzed. A threshold was set
(ST258) (Okamura et al., 2000) as previously described (Macian in the linear part of the amplification curve (fluorescence 
 f [cycle
et al., 2000). number]), and the number of cycles needed to reach it was calcu-
lated for every gene. Melting curves and agarose gel electrophoresis
Electrophoretic Mobility Shift Assays (EMSAs) established the purity of the amplified band. Normalization was
Nuclear extracts were prepared from Th1 cells, unstimulated or achieved by including a sample with primers for L32.
stimulated for 1 or 6 hr with 500 nM ionomycin or 20 nM PMA plus
500 nM ionomycin. Binding reactions were performed as previously Induction of Oral Tolerance
described (Macian et al., 2000) using probes for NFAT (distal murine OVA (20 mg/ml) was administered to DO11.10 TCR transgenic mice
IL-2 promoter), AP-1, and NF-B (Goldfeld et al., 1993). in their drinking water for 5 days, after which CD4 T cells were
isolated from spleen and lymph nodes of these mice and age- and
sex-matched controls. The ability of the control and tolerized T cellsRetroviral Infections
to initiate a productive immune response to OVA323–339 was analyzedThree different retroviral vectors were used: MSCV-containing GFP-
by measuring 3 H-thymidine incorporation during a 16 hr pulse begin-KV-DV (Wyeth Research) that expresses GFP from an IRES se-
ning 60 hr after stimulation with irradiated splenic APC pulsed withquence, GFP-KV-DV-CA-NFAT1, and GFP-KV-DV-CA-RIT-NFAT1.
different concentrations of OVA323–339.The latter two vectors were constructed by subcloning DNAs encod-
ing murine CA-NFAT1 [(ST258) NFAT1; Okamura et al., 2000]
with or without a R468A/I469A/T535G mutation (Macian et al., 2000) Acknowledgments
into GFP-KV-DV. The Phoenix ecotropic packaging cell line (kindly
provided by G.P. Nolan) was transfected with the retroviral vectors We thank members of the Rao and Byrne laboratories for valuable
discussions, K. Murphy for the original version of the retroviral vec-and supernatants were collected 24 and 48 hr later, supplemented
with polybrene (8 g/ml), and used to spin-infect (1000  g/90 min) tor, and G. Nolan for the Phoenix Ecotropic packaging cell line. This
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